MedTrace Logo

The Effectiveness of Lactoferrin in the Management of Treatment-induced Anemia

NCT03683810 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2022-09-06

No results posted yet for this study

Summary

This will be a randomised control trial designed to test the effectiveness of lactoferrin in the management of treatment-induced anemia in patients with hematological malignancies.

Conditions

Interventions

DIETARY_SUPPLEMENT

Lactoferrin

Lactoferrin in tablets 4g/daily

DRUG

Recombinant human erythropoietin

Recombinant human erythropoietin (rHuEPO, epoetin alfa)

Sponsors & Collaborators

  • Hematological Clinic - Nicosia General Hospital

    collaborator UNKNOWN

  • German Oncology Center, Cyprus

    collaborator OTHER

  • Limassol Hematology-oncology Center

    collaborator UNKNOWN

  • Cyprus University of Technology

    lead OTHER

Principal Investigators

  • Andreas CHARALAMBOUS · Cyprus University of Technology (Nursing Department)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-14
Primary Completion
2023-01-31
Completion
2023-06-30

Countries

  • Cyprus

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03683810 on ClinicalTrials.gov